<DOC>
	<DOCNO>NCT01975233</DOCNO>
	<brief_summary>An observational post-market , open label , multicenter Observatory . The decision use WEB device treat patient make independently decision include patient French Observatory .</brief_summary>
	<brief_title>WEB French Observatory WEB Aneurysm Embolization System</brief_title>
	<detailed_description>Subjects screen Observatory eligibility give informed consent . The embolization procedure perform digital angiographic suite use standard angiographic technique . Initial analysis Observatory data perform completion 12 month follow-up first thirty-five ( 35 ) subject . Subjects follow per Institution 's standard care .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>1 . The decision use WEB device treat patient make independently decision include patient French Observatory 2 . Subject must ≥ 18 year age ; 3 . Subject must intracranial aneurysm require treatment accord multidisciplinary decision . If subject additional aneurysm require treatment , additional aneurysm must require treatment within 30 day index procedure ; 4 . Aneurysm treat must follow characteristic : i. Morphology saccular ii . Location : Basilar apex ( BA ) , Middle cerebral artery ( MCA ) bifurcation , Internal carotid artery ( ICA ) terminus Anterior communicate artery ( ACom ) Anterior cerebral Artery ( ACA ) iii . Diameter width aneurysm appropriate size treatment WEB Aneurysm Embolization System per device Instructions Use iv . DometoNeck ( DN ) ratio ≥ 1.0 5 . Subject must consider physician available subsequent visit ; 6 . Subject must able comply aspect screen , evaluation , treatment , postprocedure followup schedule ; 7 . Subject must sign date CPP and/or CCTIRS/CNIL approve write informed consent prior initiation clinical evaluation procedure , include screening procedure ( unable sign self , legal representative may applicable ) . Additional inclusion criterion rupture aneurysm : For subject rupture aneurysm : subject rupture aneurysm Hunt &amp; Hess Score I , II , III 1 . Subject great 75 year age ; 2 . Subject one aneurysm require treatment within 30 day index procedure ; 3 . Subject female pregnant breastfeeding ; 4 . Subject know coagulopathy ; 5 . Subject know hemoglobinopathy thrombocytopathy ; 6 . Subject lesion characteristic unsuitable endovascular treatment ; 7 . Subject vessel , tortuosity morphology could preclude safe access support treatment clinical evaluation device ; 8 . Subject exhibit ischemic symptom transient ischemic attack , minor stroke , strokeinevolution within 30 day prior enrollment ; 9 . Subject exhibit clinical angiographic evidence vasospasm ; 10 . Subject physical , neurologic psychiatric condition , preclude Subject 's ability comply aspect screen , evaluation , treatment , postprocedure followup schedule ; 11 . Subject know hypersensitivity component clinical evaluation device , procedural material , medication commonly use procedure ; 12 . Subject receive investigational device treatment target intracranial aneurysm prior entry trial ; 13 . Subject acute lifethreatening illness neurological disease treat trial ; 14 . Subject life expectancy le 2 year due illness condition ( addition intracranial aneurysm ) ; Additional Exclusion Criteria unruptured aneurysm : 15 . Subject Computed Tomography ( CT ) Magnetic Resonance Imaging ( MRI ) evidence subarachnoid/intracranial hemorrhage presentation ; 16 . Subject circulatory , neurovascular , cardiovascular medical condition result neurological symptom ; Additional Exclusion Criteria rupture aneurysm : 17 . Subject rupture aneurysm Hunt &amp; Hess Score IV V ; Additional Imaging 18 . Subject CT MRI evidence intracranial tumor ( except small meningioma ) intracranial vascular malformation presentation ; 19 . Subject angiographic evidence vasculitis ; 20 . Microcatheter could reach Subject 's aneurysm allow necessary access treat clinical evaluation device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Endovascular</keyword>
	<keyword>Brain Aneurysm</keyword>
</DOC>